Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the U.S. healthcare system through the power of the Change Healthcare Platform. The company provides data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.
Company profile
Ticker
CHNG
Exchange
Website
CEO
Neil E. de Crescenzo
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Change Encircle, LLC • Change Healthcare Advocates, LLC • Change Healthcare Business Fulfillment, LLC • Change Healthcare Canada Company • Change Healthcare Communications, LLC • Change Healthcare Correspondence Services, Inc. • Change Healthcare Engagement Solutions, Inc. • Change Healthcare eRx Canada, Inc. • Change Healthcare Finance, Inc. • Change Healthcare HealthQx, LLC ...
IRS number
822152098
CHNG stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
13 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Oct 22
25-NSE
Exchange delisting
3 Oct 22
8-K
Termination of a Material Definitive Agreement
3 Oct 22
8-K
District Court Denies Request to Enjoin Acquisition of Change
20 Sep 22
10-Q
2023 Q1
Quarterly report
4 Aug 22
8-K
Change Healthcare Inc. Reports First Quarter Fiscal 2023 Financial Results
3 Aug 22
10-K/A
2022 FY
Annual report (amended)
29 Jul 22
8-K
Other Events
19 Jul 22
15-12G
Securities registration termination
11 Jul 22
Transcripts
CHNG
Earnings call transcript
2023 Q1
6 Aug 22
CHNG
Earnings call transcript
2022 Q4
26 May 22
CHNG
Earnings call transcript
2022 Q3
3 Feb 22
CHNG
Earnings call transcript
2022 Q2
7 Nov 21
CHNG
Earnings call transcript
2022 Q1
7 Aug 21
CHNG
Earnings call transcript
2021 Q4
27 May 21
CHNG
Earnings call transcript
2021 Q3
4 Feb 21
CHNG
Earnings call transcript
2021 Q2
7 Nov 20
CHNG
Earnings call transcript
2021 Q1
9 Aug 20
CHNG
Earnings call transcript
2020 Q4
4 Jun 20
Latest ownership filings
SC 13G/A
ABRAMS CAPITAL MANAGEMENT, L.P.
2 Feb 23
SC 13D
Farallon Capital Partners, L.P.
7 Oct 22
4
Paul Rareshide
5 Oct 22
4
Nella Domenici
5 Oct 22
4
Kriten Joshi
5 Oct 22
4
PHILIP M PEAD
5 Oct 22
4
Crescenzo Neil E. De
5 Oct 22
4
Thomas Laur
5 Oct 22
4
Fredrik J Eliasson
5 Oct 22
4
DIANA MCKENZIE
5 Oct 22
Financial summary
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 22 | Mar 21 | Mar 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 94.01 mm | 94.01 mm | 94.01 mm | 94.01 mm | 94.01 mm | 94.01 mm |
Cash burn (monthly) | 52.76 mm | 1.26 mm | 10.83 mm | 5.62 mm | (no burn) | (no burn) |
Cash used (since last report) | 1.15 bn | 27.44 mm | 236.19 mm | 122.51 mm | n/a | n/a |
Cash remaining | -1.06 bn | 66.57 mm | -142.18 mm | -28.50 mm | n/a | n/a |
Runway (months of cash) | -20.0 | 52.9 | -13.1 | -5.1 | n/a | n/a |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 16.84 bn |
Total shares | 830.84 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
UNH Unitedhealth | 590.46 mm | $10.77 bn |
Farallon Capital Partners | 180.76 mm | $4.96 bn |
Blackstone Holdings III | 59.62 mm | $1.11 bn |